153 related articles for article (PubMed ID: 38352263)
61. Reversible methotrexate-associated lymphoproliferative disorder resembling advanced gastric cancer in a patient with rheumatoid arthritis.
Satoh K; Yoshida N; Imaizumi K; Yajima M; Wakui H; Sawada K; Komatsuda A
Am J Med Sci; 2009 Oct; 338(4):334-5. PubMed ID: 19745701
[TBL] [Abstract][Full Text] [Related]
62. Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients.
Kameda T; Dobashi H; Miyatake N; Inoo M; Onishi I; Kurata N; Mitsunaka H; Kawakami K; Fukumoto T; Susaki K; Izumikawa M; Nakashima S; Shimada H; Takeuchi Y; Haba R; Mano S; Onishi H; Imataki O; Matsunaga T
Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1302-9. PubMed ID: 24515570
[TBL] [Abstract][Full Text] [Related]
63. CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy.
Hatachi S; Kunitomi A; Aozasa K; Yagita M
Mod Rheumatol; 2010 Oct; 20(5):500-5. PubMed ID: 20437072
[TBL] [Abstract][Full Text] [Related]
64. The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
Watanabe S; Manabe O; Hirata K; Oyama-Manabe N; Hattori N; Kikuchi Y; Kobayashi K; Toyonaga T; Tamaki N
BMC Cancer; 2016 Aug; 16():635. PubMed ID: 27528380
[TBL] [Abstract][Full Text] [Related]
65. Distinct decrease in peripheral lymphocytes in EBER-positive cases of MTX-LPD.
Kondo M; Murakawa Y; Moriyama M; Honda M; Sugiura T; Onoda K; Watanabe Y; Kakimaru H
Mod Rheumatol; 2021 Jan; 31(1):88-93. PubMed ID: 32075469
[TBL] [Abstract][Full Text] [Related]
66. Epstein-Barr virus-infected subcutaneous panniculitis-like T-cell lymphoma associated with methotrexate treatment.
Nemoto Y; Taniguchi A; Kamioka M; Nakaoka Y; Hiroi M; Yokoyama A; Enzan H; Daibata M
Int J Hematol; 2010 Sep; 92(2):364-8. PubMed ID: 20665252
[TBL] [Abstract][Full Text] [Related]
67. Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions.
Shiraiwa S; Kikuti YY; Carreras J; Hara R; Aoyama Y; Ogiya D; Suzuki R; Toyosaki M; Ohmachi K; Ogawa Y; Kawada H; Sato S; Nakamura N; Ando K
J Clin Exp Hematop; 2020 Dec; 60(4):159-168. PubMed ID: 33148934
[TBL] [Abstract][Full Text] [Related]
68. Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders.
Kakiuchi S; Yakushijin K; Takagi I; Rikitake J; Akiyama H; Matsuba H; Hayashi Y; Kajimoto K; Iwata N
Front Med (Lausanne); 2020; 7():625442. PubMed ID: 33425968
[TBL] [Abstract][Full Text] [Related]
69. Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features.
Namiki T; Sone Y; Miura K; Tanaka M; Yokozeki H
Case Rep Dermatol; 2018; 10(2):149-153. PubMed ID: 29928205
[TBL] [Abstract][Full Text] [Related]
70. Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.
Ejima-Yamada K; Oshiro Y; Okamura S; Fujisaki T; Mihashi Y; Tamura K; Fukushige T; Kojima M; Shibuya K; Takeshita M
Virchows Arch; 2017 Feb; 470(2):205-215. PubMed ID: 27864689
[TBL] [Abstract][Full Text] [Related]
71. [Methotrexate-related lymphoproliferative disease showing different histological findings at recurrence].
Kato T; Imaizumi Y; Itonaga H; Sato S; Ando K; Sawayama Y; Ichinose K; Miyoshi H; Ohshima K; Miyazaki Y
Rinsho Ketsueki; 2023; 64(2):97-101. PubMed ID: 36990739
[TBL] [Abstract][Full Text] [Related]
72. Pneumonia and Meningoencephalitis Due to Varicella-zoster Virus Reinfection and Epstein-Barr Virus Reactivation in a Patient with Rheumatoid Arthritis.
Ito N; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Chayama K; Hattori N
Intern Med; 2022 Oct; 61(19):2961-2965. PubMed ID: 35249916
[TBL] [Abstract][Full Text] [Related]
73. Epstein-Barr virus-related diffuse large B-cell lymphoma type methotrexate-associated lymphoproliferative disorders presenting in the adrenal gland.
Doi K; Muramaki M; Yamamoto T; Katsura D; Fukunaga H; Takahashi K; Matsumoto M; Yamada Y
IJU Case Rep; 2022 May; 5(3):172-174. PubMed ID: 35509787
[TBL] [Abstract][Full Text] [Related]
74. Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate Treatment.
Saito S; Suzuki K; Yoshimoto K; Kaneko Y; Yamaoka K; Shimizu T; Mori T; Okamoto S; Kameyama K; Amano K; Tamaru JI; Tokuhira M; Takeuchi T
Front Immunol; 2018; 9():621. PubMed ID: 29670617
[TBL] [Abstract][Full Text] [Related]
75. Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases.
Koens L; Senff NJ; Vermeer MH; Willemze R; Jansen PM
Am J Surg Pathol; 2014 Jul; 38(7):999-1006. PubMed ID: 24805861
[TBL] [Abstract][Full Text] [Related]
76. [Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis].
Uchida Y; Hokkoku K; Hatanaka Y; Kikuchi Y; Tashiro H; Sonoo M
Rinsho Shinkeigaku; 2018 Aug; 58(8):485-491. PubMed ID: 30068810
[TBL] [Abstract][Full Text] [Related]
77. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection.
Lioté F; Pertuiset E; Cochand-Priollet B; D'Agay MF; Dombret H; Numéric P; D'Anglejan G; Kuntz D
J Rheumatol; 1995 Jun; 22(6):1174-8. PubMed ID: 7674250
[TBL] [Abstract][Full Text] [Related]
78. Methotrexate-associated Lymphoproliferative Disorder of the Stomach Presumed to Be Mucosa-associated Lymphoid Tissue Lymphoma.
Ishigaki S; Masaoka T; Kameyama H; Kawaida M; Kameyama K; Mori T; Kanai T
Intern Med; 2018; 57(22):3249-3254. PubMed ID: 30429434
[TBL] [Abstract][Full Text] [Related]
79. Polymorphic lymphoproliferative disorders in patients with rheumatoid arthritis are associated with a better clinical outcome.
Tsukui D; Kanda H; Shinozaki-Ushiku A; Tateishi S; Takeshima Y; Nagafuchi Y; Sasaki O; Iwasaki Y; Harada H; Shibuya M; Sumitomo S; Shoda H; Kubo K; Fujio K; Nakamura F; Kurokawa M; Fukayama M; Yamamoto K
Mod Rheumatol; 2018 Jul; 28(4):621-625. PubMed ID: 29057700
[TBL] [Abstract][Full Text] [Related]
80. Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder.
Ueno H; Ohno N; Abe T; Kimoto K; Matsuoka C; Giga M; Naito H; Kono T; Takasu M; Kidani N; Yamasaki R; Ichimura K; Nomura E
Intern Med; 2022 Dec; 61(24):3733-3738. PubMed ID: 35598995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
